Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

544 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Methylprednisolone-induced immune thrombocytopenia.
Dubert M, Le Toriellec E, Croisille L, Thomas L, Ducreux M, Froissart A, Herbrecht R, Lebrun-Vignes B, Marolleau JP, Méric JB, Mahevas M, Michel M, Bierling P. Dubert M, et al. Among authors: ducreux m. Am J Hematol. 2020 Jan;95(1):E13-E16. doi: 10.1002/ajh.25645. Epub 2019 Oct 31. Am J Hematol. 2020. PMID: 31598982 Free article. No abstract available.
Rechallenge After Oxaliplatin-Induced Hypersensitivity Reactions.
Rassy E, Le Roy F, Smolenschi C, Valéry M, Boige V, Ducreux M, Boilève A. Rassy E, et al. Among authors: ducreux m. JAMA Oncol. 2023 Mar 1;9(3):434-435. doi: 10.1001/jamaoncol.2022.7136. JAMA Oncol. 2023. PMID: 36701137 Free PMC article.
Precision Medicine in Pancreatic Ductal Adenocarcinoma: The Impact of Targeted Therapies on Survival of Patients Harboring Actionable Mutations.
Tarabay A, Boileve A, Smolenschi C, Antoun L, Valery M, Fuerea A, Perret A, Burtin P, Cosconea S, Belkhodja H, Malka D, Boige V, Hollebecque A, Ducreux M. Tarabay A, et al. Among authors: ducreux m. Biomedicines. 2023 Sep 19;11(9):2569. doi: 10.3390/biomedicines11092569. Biomedicines. 2023. PMID: 37761010 Free PMC article.
Molecular profiling of biliary tract cancers reveals distinct genomic landscapes between circulating and tissue tumor DNA.
Astier C, Ngo C, Colmet-Daage L, Marty V, Bawa O, Nicotra C, Ngo-Camus M, Italiano A, Massard C, Scoazec JY, Smolenschi C, Ducreux M, Hollebecque A, Postel-Vinay S. Astier C, et al. Among authors: ducreux m. Exp Hematol Oncol. 2024 Jan 8;13(1):2. doi: 10.1186/s40164-023-00470-7. Exp Hematol Oncol. 2024. PMID: 38191492 Free PMC article.
Adjuvant and neoadjuvant approaches in pancreatic cancer.
Conroy T, Lambert A, Ducreux M. Conroy T, et al. Among authors: ducreux m. Curr Opin Oncol. 2023 Jul 1;35(4):326-333. doi: 10.1097/CCO.0000000000000962. Epub 2023 May 12. Curr Opin Oncol. 2023. PMID: 37222189 Review.
Early evaluation using a radiomic signature of unresectable hepatic metastases to predict outcome in patients with colorectal cancer treated with FOLFIRI and bevacizumab.
Dohan A, Gallix B, Guiu B, Le Malicot K, Reinhold C, Soyer P, Bennouna J, Ghiringhelli F, Barbier E, Boige V, Taieb J, Bouché O, François E, Phelip JM, Borel C, Faroux R, Seitz JF, Jacquot S, Ben Abdelghani M, Khemissa-Akouz F, Genet D, Jouve JL, Rinaldi Y, Desseigne F, Texereau P, Suc E, Lepage C, Aparicio T, Hoeffel C; PRODIGE 9 Investigators and PRODIGE 20 Investigators. Dohan A, et al. Gut. 2020 Mar;69(3):531-539. doi: 10.1136/gutjnl-2018-316407. Epub 2019 May 17. Gut. 2020. PMID: 31101691
Second-look surgery plus hyperthermic intraperitoneal chemotherapy versus surveillance in patients at high risk of developing colorectal peritoneal metastases (PROPHYLOCHIP-PRODIGE 15): a randomised, phase 3 study.
Goéré D, Glehen O, Quenet F, Guilloit JM, Bereder JM, Lorimier G, Thibaudeau E, Ghouti L, Pinto A, Tuech JJ, Kianmanesh R, Carretier M, Marchal F, Arvieux C, Brigand C, Meeus P, Rat P, Durand-Fontanier S, Mariani P, Lakkis Z, Loi V, Pirro N, Sabbagh C, Texier M, Elias D; BIG-RENAPE group. Goéré D, et al. Lancet Oncol. 2020 Sep;21(9):1147-1154. doi: 10.1016/S1470-2045(20)30322-3. Epub 2020 Jul 24. Lancet Oncol. 2020. PMID: 32717180 Clinical Trial.
544 results